These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 17007263)
1. [Assessment of malonyldialdehyde concentration as a product of lipid peroxidation and lipid metabolism in patients on chronic dialysis]. Miler M; Zamojska S; Fijałkowski P; Lobos M; Paradowski MT Pol Merkur Lekarski; 2006 Jun; 20(120):664-7. PubMed ID: 17007263 [TBL] [Abstract][Full Text] [Related]
2. Lipoproteins and lipid peroxidation abnormalities in patients with chronic renal disease. Ong-Ajyooth L; Ong-Ajyooth S; Sirisalee K; Nilwarangkur S J Med Assoc Thai; 1996 Aug; 79(8):505-12. PubMed ID: 8855633 [TBL] [Abstract][Full Text] [Related]
3. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis]. Zwolińska D; Szprynger K Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806 [TBL] [Abstract][Full Text] [Related]
4. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709 [TBL] [Abstract][Full Text] [Related]
5. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment. Göçmen AY; Sahin E; Koçak H; Tuncer M; Gümüşlü S Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672 [TBL] [Abstract][Full Text] [Related]
6. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis. Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752 [TBL] [Abstract][Full Text] [Related]
7. Renal function and lipid metabolism in pregnant renal transplant recipients. Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508 [TBL] [Abstract][Full Text] [Related]
9. Lipoperoxidation and hemodialysis. Ramos R; Martínez-Castelao A Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940 [TBL] [Abstract][Full Text] [Related]
10. [Lipoprotein (a) in children with chronic renal failure treated conservatively]. Zwolińska D; Kiliś-Pstrusińska K; Szprynger K Pol Merkur Lekarski; 1997 Sep; 3(15):126-8. PubMed ID: 9461709 [TBL] [Abstract][Full Text] [Related]
11. Does ingestion of regular coffee influence serum lipid profile in dialysis patients? Grzegorzewska AE; Młot-Michalska M; Wobszal P Adv Perit Dial; 2009; 25():181-6. PubMed ID: 19886342 [TBL] [Abstract][Full Text] [Related]
12. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Svensson M; Schmidt EB; Jørgensen KA; Christensen JH Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564 [TBL] [Abstract][Full Text] [Related]
13. [Changes in the spectra of lipoproteins and phospholipids in the blood serum of patients with chronic renal failure placed on programmed hemodialysis]. Rozental' RL; Pirogova TF; Zezina LIu Ter Arkh; 1989; 61(6):99-101. PubMed ID: 2799729 [TBL] [Abstract][Full Text] [Related]
14. Assessment of lipid dysfunction in patients on maintenance haemodialysis. Altaf A; Halim A; Khan DA; Khalid M; Fatima-Tuz-Zuhra ; Saif I J Ayub Med Coll Abbottabad; 2007; 19(4):32-6. PubMed ID: 18693593 [TBL] [Abstract][Full Text] [Related]
15. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia. Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148 [TBL] [Abstract][Full Text] [Related]
16. Oxidative stress in haemodialysis. Loughrey CM; Young IS; Lightbody JH; McMaster D; McNamee PT; Trimble ER QJM; 1994 Nov; 87(11):679-83. PubMed ID: 7820542 [TBL] [Abstract][Full Text] [Related]
17. [Malondialdehyde concentration in the serum of children with chronic renal failure, chronic hemodialysis and kidney transplantation]. Otting U; Hellmann C Z Urol Nephrol; 1990 Mar; 83(3):141-8. PubMed ID: 2356668 [TBL] [Abstract][Full Text] [Related]
18. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients. De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746 [TBL] [Abstract][Full Text] [Related]
19. [Lipid status in patients on a chronic hemodialysis program]. Tepsić V; Ristić V; Perunicić G; Rasić Z; Pljesa S; Bokan L; Ranković N Med Pregl; 1997; 50(1-2):45-7. PubMed ID: 9132551 [TBL] [Abstract][Full Text] [Related]
20. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients. Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]